Earnings Feed
Start Free
Home/Filings/3/0001179110-10-016539
3//SEC Filing

RHO MANAGEMENT VENTURES IV LLC 3

Accession 0001179110-10-016539

CIK 0001411158other
View on SEC.govCompany Profile

Filed

Nov 22, 7:00 PM ET

Accepted

Nov 23, 6:24 PM ET

Size

29.0 KB

Accession

0001179110-10-016539

Insider Transaction Report

Form 3
Period: 2010-11-23
Anacor Pharmaceuticals IncANAC
RHO CAPITAL PARTNERS VERWALTUNGS GMBH
10% Owner
Holdings

  • Series C Preferred Stock

    (indirect: See Footnote)
    → Common Stock (1,752,807 underlying)

  • Series B Preferred Stock

    (indirect: See Footnote)
    → Common Stock (527,469 underlying)

  • Series E Preferred Stock

    (indirect: See Footnote)
    → Common Stock (221,235 underlying)

  • Series A-1 Preferred Stock

    (indirect: See Footnote)
    → Common Stock (507,398 underlying)

  • Series D Preferred Stock

    (indirect: See Footnote)
    → Common Stock (212,514 underlying)
RHO VENTURES IV QP LP
10% Owner
Holdings

  • Series C Preferred Stock

    (indirect: See Footnote)
    → Common Stock (1,752,807 underlying)

  • Series E Preferred Stock

    (indirect: See Footnote)
    → Common Stock (221,235 underlying)

  • Series A-1 Preferred Stock

    (indirect: See Footnote)
    → Common Stock (507,398 underlying)

  • Series D Preferred Stock

    (indirect: See Footnote)
    → Common Stock (212,514 underlying)

  • Series B Preferred Stock

    (indirect: See Footnote)
    → Common Stock (527,469 underlying)
RHO MANAGEMENT TRUST I
10% Owner
Holdings

  • Series D Preferred Stock

    (indirect: See Footnote)
    → Common Stock (212,514 underlying)

  • Series C Preferred Stock

    (indirect: See Footnote)
    → Common Stock (1,752,807 underlying)

  • Series A-1 Preferred Stock

    (indirect: See Footnote)
    → Common Stock (507,398 underlying)

  • Series B Preferred Stock

    (indirect: See Footnote)
    → Common Stock (527,469 underlying)

  • Series E Preferred Stock

    (indirect: See Footnote)
    → Common Stock (221,235 underlying)
RHO VENTURES IV GMBH & CO BETEILIGUNGS KG
10% Owner
Holdings

  • Series C Preferred Stock

    (indirect: See Footnote)
    → Common Stock (1,752,807 underlying)

  • Series B Preferred Stock

    (indirect: See Footnote)
    → Common Stock (527,469 underlying)

  • Series E Preferred Stock

    (indirect: See Footnote)
    → Common Stock (221,235 underlying)

  • Series A-1 Preferred Stock

    (indirect: See Footnote)
    → Common Stock (507,398 underlying)

  • Series D Preferred Stock

    (indirect: See Footnote)
    → Common Stock (212,514 underlying)
RHO CAPITAL PARTNERS INC
10% Owner
Holdings

  • Series C Preferred Stock

    (indirect: See Footnote)
    → Common Stock (1,752,807 underlying)

  • Series B Preferred Stock

    (indirect: See Footnote)
    → Common Stock (527,469 underlying)

  • Series D Preferred Stock

    (indirect: See Footnote)
    → Common Stock (212,514 underlying)

  • Series A-1 Preferred Stock

    (indirect: See Footnote)
    → Common Stock (507,398 underlying)

  • Series E Preferred Stock

    (indirect: See Footnote)
    → Common Stock (221,235 underlying)
RHO VENTURES IV LP
10% Owner
Holdings

  • Series C Preferred Stock

    (indirect: See Footnote)
    → Common Stock (1,752,807 underlying)

  • Series A-1 Preferred Stock

    (indirect: See Footnote)
    → Common Stock (507,398 underlying)

  • Series B Preferred Stock

    (indirect: See Footnote)
    → Common Stock (527,469 underlying)

  • Series E Preferred Stock

    (indirect: See Footnote)
    → Common Stock (221,235 underlying)

  • Series D Preferred Stock

    (indirect: See Footnote)
    → Common Stock (212,514 underlying)
RHO MANAGEMENT VENTURES IV LLC
10% Owner
Holdings

  • Series A-1 Preferred Stock

    (indirect: See Footnote)
    → Common Stock (507,398 underlying)

  • Series B Preferred Stock

    (indirect: See Footnote)
    → Common Stock (527,469 underlying)

  • Series C Preferred Stock

    (indirect: See Footnote)
    → Common Stock (1,752,807 underlying)

  • Series D Preferred Stock

    (indirect: See Footnote)
    → Common Stock (212,514 underlying)

  • Series E Preferred Stock

    (indirect: See Footnote)
    → Common Stock (221,235 underlying)
RUCH JOSHUA
10% Owner
Holdings

  • Series A-1 Preferred Stock

    (indirect: See Footnote)
    → Common Stock (507,398 underlying)

  • Series D Preferred Stock

    (indirect: See Footnote)
    → Common Stock (212,514 underlying)

  • Series B Preferred Stock

    (indirect: See Footnote)
    → Common Stock (527,469 underlying)

  • Series E Preferred Stock

    (indirect: See Footnote)
    → Common Stock (221,235 underlying)

  • Series C Preferred Stock

    (indirect: See Footnote)
    → Common Stock (1,752,807 underlying)
KAIROUZ HABIB
10% Owner
Holdings

  • Series A-1 Preferred Stock

    (indirect: See Footnote)
    → Common Stock (507,398 underlying)

  • Series D Preferred Stock

    (indirect: See Footnote)
    → Common Stock (212,514 underlying)

  • Series C Preferred Stock

    (indirect: See Footnote)
    → Common Stock (1,752,807 underlying)

  • Series E Preferred Stock

    (indirect: See Footnote)
    → Common Stock (221,235 underlying)

  • Series B Preferred Stock

    (indirect: See Footnote)
    → Common Stock (527,469 underlying)
Footnotes (7)
  • [F1]The preferred stock is convertible at any time, at the holder's election, on a one-for-one basis (other than the Series B Preferred Stock, which converts on a 1 to 1.316 basis) and has no expiration date. The preferred stock will automatically convert into shares of Common Stock on a one-for-one basis (other than the Series B Preferred Stock, which will convert on a 1 to 1.316 basis) upon the closing of the Issuer's initial public offering, subject to certain conditions.
  • [F2]Consists of 63,531 shares held by Rho Ventures IV, L.P. ("RV IV"), 155,873 shares held by Rho Ventures IV GmbH & Co. Beteilgungs KG ("RV KG"), 149,569 shares held by Rho Ventures IV (QP), L.P. ("RV QP"), and 138,425 shares held by Rho Management Trust I ("RMT I").
  • [F3]Consists of 66,044 shares held by RV IV, 162,038 shares held by RV KG, 155,486 shares held by RV QP, and 143,901 shares held by RMT I.
  • [F4]Consists of 219,469 shares held by RV IV, 538,462 shares held by RV KG, 516,687 shares held by RV QP, and 478,189 shares held by RMT I.
  • [F5]Consists of 26,609 shares held by RV IV, 65,284 shares held by RV KG, 62,644 shares held by RV QP, and 57,977 shares held by RMT I.
  • [F6]Consists of 27,701 shares held by RV IV, 67,963 shares held by RV KG, 65,215 shares held by RV QP, and 60,356 shares held by RMT I.
  • [F7]Rho Management Ventures IV, L.L.C. ("RMV") is the general partner of RV IV and RV QP, Rho Capital Partners Verwaltungs GmbH ("RCP GmbH") is the general partner of RV KG, and Rho Capital Partners, Inc. ("RCP") is the investment advisor to RMT I. Each of RMV, RCP GmbH and RCP disclaims beneficial ownership of the reportable securities and this report shall not be deemed an admission that such filer is the beneficial owner of such securities, except to the extent of its pecuniary interest therein. Habib Kairouz and Joshua Ruch are managing members of RMV, managing directors of RCP GmbH and managing partners of RCP. Each of Habib Kairouz and Joshua Ruch disclaim beneficial ownership of the reportable securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of his pecuniary interest therein.

Documents

2 files

Issuer

Anacor Pharmaceuticals Inc

CIK 0001411158

→
Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001269064

Filing Metadata

Form type
3
Filed
Nov 22, 7:00 PM ET
Accepted
Nov 23, 6:24 PM ET
Size
29.0 KB
View on SEC.gov